Related Experiment Video
Updated: Jun 8, 2025
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
18.4K
Schizophrenia - new treatments soon
1Division of Psychological Medicine and Clinical Neurosciences, and Neuroscience and Mental Health Innovation Institute, Cardiff University, Cardiff, UK.
The British Journal of Psychiatry : the Journal of Mental Science
|November 8, 2024
Summary
New treatments for schizophrenia show promise. Muscarinic acetylcholinergic receptor agonists may improve psychotic and negative symptoms, offering a novel therapeutic avenue beyond traditional dopamine-targeting antipsychotics.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Antipsychotic medications primarily target dopamine receptors and have been used for 70 years.
- Schizophrenia treatment remains a significant clinical challenge, with unmet needs for negative and cognitive symptoms.
Purpose of the Study:
- To review the emerging therapeutic strategy of targeting muscarinic acetylcholinergic receptors for schizophrenia.
- To discuss the potential clinical applications and anticipated licensing of these novel agents.
Main Methods:
- Review of recent clinical trial data.
- Analysis of pharmacological mechanisms of muscarinic agonists.
- Synthesis of current research on novel schizophrenia treatments.
Main Results:
- Agonists of muscarinic acetylcholinergic receptors demonstrate efficacy in improving both psychotic and negative symptoms.
- This approach represents a significant departure from traditional dopamine-receptor blockade.
Conclusions:
- Muscarinic acetylcholinergic receptor agonists offer a promising new class of medications for schizophrenia.
- These agents are anticipated to be clinically licensed, expanding treatment options for patients.
Related Concept Videos
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
01:26Psychosis: Goals of Pharmacotherapy
104
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
104
01:28Psychosis and Antipsychotic Drugs: Overview
179
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
179
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
121
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
121
01:23Antidepressant Drugs: MAOIs and Other Agents
195
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
195
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
473
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
473